Expanding the Spectrum of HER2 Positivity for Breast Cancer Care: Implications of HER2-Low Status

Get up to date on best practices for assessing HER2 status and treating patients with HER2-low breast cancer with downloadable slides from a satellite symposium at SABCS 2022 an on-demand webcast and an expert commentary.

Share

Program Content

Activities

BC: Implications of HER2-Low
Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 08, 2022

Expires: December 07, 2023

Precision Care:  HER2-low ABC
ExpressPoints
Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 16, 2022

Expires: December 15, 2023

Activities

FAQs: T-DXd in HER2-Low ABC
Frequently Asked Questions: Expanding the Spectrum of HER2 Positivity in Advanced Breast Cancer With T-DXd
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 13, 2023

Expires: February 12, 2024

Activities

HER2-low ABC
Expanding the Spectrum of HER2 Positivity for Precision Breast Cancer Care: Clinical Implications of HER2-Low Status
Video
Congratulations: You achieved a completion on 04/09/2022

Released: January 19, 2023

Expires: January 18, 2024

Faculty

cover img faculity

Nadia Harbeck, MD, PhD

Full Professor
Director
Breast Center, LMU University Hospital
Ludwig-Maximilians University
Munich, Germany

cover img faculity

Komal Jhaveri, MD, FACP

Associate Attending
Breast Medicine Service and Early Drug Development Service
Section Head, Endocrine Therapy Research Program
Clinical Director, Early Drug Development Service
Department of Medicine
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

cover img faculity

Heather McArthur, MD, MPH

Associate Professor
Department of Internal Medicine
Clinical Director, Breast Cancer Program
Komen Distinguished Chair in Clinical Breast Cancer Research
UT Southwestern Medical Center
Dallas, Texas

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca Pharmaceuticals

Daiichi Sankyo, Inc.